EudraCT Number: 2007-001717-42 Sponsor Protocol Number: P05175 Start Date: 2007-10-25
Sponsor Name: Schering Plough Research Institute
Full Title: A Phase 2, 36 Week, Open-Label, Uncontrolled Safety Follow-Up Study Assessing SCH 420814 5 mg BID
Medical condition: Patients with Moderate to Severe Parkinson's Disease Experiencing Motor Fluctuations and Dyskinesias
Disease: Version SOC Term Classification Code Term Level
Population Age: Adults, Elderly Gender: Male, Female
Trial protocol: FR (Ongoing) ES (Ongoing)
Trial results: View results
EudraCT Number: 2005-000832-26 Sponsor Protocol Number: 2005 02 03 Start Date: 2006-01-25
Sponsor Name: Department of Endocrinology
Full Title: Adjuvant treatment of Graves´ ophthalmopathy with NSAID (aGO study)
Medical condition: Graves´ophthalmopathy
Disease: Version SOC Term Classification Code Term Level
Population Age: Adults, Elderly Gender: Male, Female
Trial protocol: SE (Ongoing)
Trial results: (No results available)
EudraCT Number: 2005-003432-22 Sponsor Protocol Number: EGF104383 Start Date: 2008-07-03
Sponsor Name: Glaxo SmithKline Research and Development Limited
Full Title: A Randomized, Double Blind, Placebo-Controlled, Multicenter, Phase III Study Comparing the Activity of Paclitaxel Plus Trastuzumab Plus Lapatinib to Paclitaxel Plus Trastuzumab Plus Placebo in Wome...
Medical condition: ErbB2+ Metastatic Breast Cancer
Disease: Version SOC Term Classification Code Term Level
9.1 10027475 Metastatic breast cancer LLT
Population Age: Adults, Elderly Gender: Female
Trial protocol: BE (Completed)
Trial results: (No results available)
EudraCT Number: 2005-003438-17 Sponsor Protocol Number: 05/Q1606/143 Start Date: 2005-11-07
Sponsor Name: Oxford Radcliffe Hospitals NHS Trust
Full Title: SimSepT: Simvastatin and severe sepsis in the ICU
Medical condition: Severe sepsis
Disease: Version SOC Term Classification Code Term Level
Population Age: Adolescents, Under 18, Adults, Elderly Gender: Male, Female
Trial protocol: GB (Ongoing)
Trial results: (No results available)
EudraCT Number: 2006-002000-34 Sponsor Protocol Number: CLOZAPINA-1 Start Date: 2007-04-09
Sponsor Name: Fundación Cerebro y Mente
Full Title: CLOZAPINA EN PRIMEROS BROTES DE ESQUIZOFRENIA COMO POSIBLE TRATAMIENTO PREVENTIVO DEL DETERIORO CEREBRAL Y CLINICO
Medical condition: Schizophrenia
Disease: Version SOC Term Classification Code Term Level
Population Age: Adults Gender: Male, Female
Trial protocol: ES (Ongoing)
Trial results: (No results available)
EudraCT Number: 2006-002010-35 Sponsor Protocol Number: TinnEx Start Date: 2006-12-14
Sponsor Name: Prof. Herta Flor, Head of the Institute of Clinical and Cognitive Neuroscience
Full Title: An Extinction Training in Tinnitus
Medical condition: The effect of pregabalin on the success to reduce the interference by tinnitus by an extinction training is tested in chronic tinnitus sufferers.
Disease: Version SOC Term Classification Code Term Level
Population Age: Adults Gender: Male, Female
Trial protocol: DE (Ongoing)
Trial results: (No results available)
EudraCT Number: 2006-002037-20 Sponsor Protocol Number: GA/9016 Start Date: 2006-07-27
Sponsor Name: Teva Pharmaceutical Industries, Ltd.
Full Title: A multi-national, multi-centre, randomized, parallel-group, double-blind study to compare the efficacy, tolerability and safety of Glatiramer Acetate Injection 40 mg/ml to that of Glatiramer Acetat...
Medical condition: Relapsing-remitting Multiple Sclerosis (RR MS)
Disease: Version SOC Term Classification Code Term Level
8.1 10028245 PT
Population Age: Adults Gender: Male, Female
Trial protocol: HU (Prematurely Ended) FI (Prematurely Ended) ES (Prematurely Ended) BE (Completed) GB (Prematurely Ended) LV (Prematurely Ended) CZ (Prematurely Ended) IT (Prematurely Ended) LT (Prematurely Ended) DE (Prematurely Ended) EE (Prematurely Ended)
Trial results: View results
EudraCT Number: 2005-002241-39 Sponsor Protocol Number: BO 18192 Start Date: 2005-11-09
Sponsor Name: F. Hoffmann-La Roche Ltd
Full Title: A multicentre, double-blind randomised, phase III study to evaluate the efficacy of Tarceva or placebo following 4 cycles of platinum-based chemotherapy in patients with histologically documented a...
Medical condition: Advanced (stage IIIB or IV) NSCLC previously treated with 4 cycles of a platinum-based chemotherapy
Disease: Version SOC Term Classification Code Term Level
Population Age: Adults, Elderly Gender: Male, Female
Trial protocol: HU (Completed) ES (Ongoing) SI (Completed) GB (Completed) AT (Completed) LT (Completed) SK (Completed) PT (Prematurely Ended) DE (Completed) DK (Completed) CZ (Completed) IT (Completed) GR (Completed)
Trial results: View results
EudraCT Number: 2005-002247-86 Sponsor Protocol Number: 602030 Start Date: 2005-12-05
Sponsor Name: Royal Devon and Exeter NHS Foundation Trust
Full Title: Peripheral Blood Stem Cell Mobilisation with Cyclophosphamide and Methylprednisolone in Patients with Myeloma and Indolent Lymphoma– a prospective single arm study with historical controls
Medical condition: Plasma cell myeloma Non hodgkins lymphomas - follicular lymphoma, Mantle cell lymphoma, Lymphoplasmacytic lymphoma
Disease: Version SOC Term Classification Code Term Level
Population Age: Adults, Elderly Gender: Male, Female
Trial protocol: GB (Prematurely Ended)
Trial results: (No results available)
EudraCT Number: 2006-002273-41 Sponsor Protocol Number: OPHT-110106 Start Date: 2006-06-12
Sponsor Name: Medical University of Vienna; Clinical Pharmacology
Full Title: Effect of antioxidants on ocular blood flow, endothelial function, and cytokine levels in LPS induced inflammatory model in humans.
Medical condition: only healthy volunteers are involved
Disease: Version SOC Term Classification Code Term Level
Population Age: Adults Gender: Male
Trial protocol: AT (Completed)
Trial results: (No results available)
Medical Conditions
Sponsors and Collaborators
Drug Interventions